Company Description

Hepion Pharmaceuticals, formerly ContraVir, Ciclofilin & Isotechnika, is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).